Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identification of residue 63 as beta-hydroxyaspartic acid
about
Sequence of the cDNA encoding the laminin B1 chain reveals a multidomain protein containing cysteine-rich repeatsComplete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1rHuman Protein ZCharacterization of an almost full-length cDNA coding for human blood coagulation factor XCharacterization of a cDNA coding for human factor XVaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factorsIsolation and sequence of the cDNA for human protein S, a regulator of blood coagulationSPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrixCharacterization of a cDNA coding for human factor VIIHydroxylation of aspartic acid in domains homologous to the epidermal growth factor precursor is catalyzed by a 2-oxoglutarate-dependent dioxygenase.Aspartyl beta-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IX.Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion.The cDNA sequence of human endothelial cell multimerin. A unique protein with RGDS, coiled-coil, and epidermal growth factor-like domains and a carboxyl terminus similar to the globular domain of complement C1q and collagens type VIII and X.Protein Hydroxylation Catalyzed by 2-Oxoglutarate-dependent Oxygenases.Identification of erythro-beta-hydroxyasparagine in the EGF-like domain of human C1r.beta-Hydroxyasparagine in domains homologous to the epidermal growth factor precursor in vitamin K-dependent protein SThe role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IXMass spectrometry based analysis of human plasma-derived factor X revealed novel post-translational modifications.Transcriptional regulation of the gene coding for human protein C.The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement systemActivation mechanisms of coagulation factor IX.Epidermal growth factor-like domains in the vitamin K-dependent clotting factors. Some structure-function relationships.Intrinsic versus extrinsic coagulation. Kinetic considerations.Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa.Beta-methylthio-aspartic acid: identification of a novel posttranslational modification in ribosomal protein S12 from Escherichia coli.Disulphide bridges of bovine factor X.Defining the factor Xa-binding site on factor Va by site-directed glycosylation.Amino acid sequence of bovine protein Z: a vitamin K-dependent serine protease homolog.Molecular evolution caught in action: gene duplication and evolution of molecular isoforms of prothrombin activators in Pseudonaja textilis (brown snake).Beta-hydroxyaspartic acid in vitamin K-dependent plasma proteins from scorbutic and warfarin-treated guinea pigs.
P2860
Q24299121-38AB8556-851F-43CC-8507-75CCEB03BBE8Q24529323-18348EC6-2998-4747-BB95-16C0C86B1AB8Q24563440-196E3D5D-1106-4B24-B6B0-78B6E9B01DF0Q24567735-3AA1338A-3BBD-4B20-8391-9D3E2F048DD3Q24595573-B220569A-FC95-49E8-A1E5-8B127DD5375CQ24606243-07DCD9CC-71F8-4843-8951-0AEE89F35E80Q24629960-3230A30D-AB4F-4267-9D75-FD0A1526B8F1Q24679549-23154653-3096-45E4-9660-819305DC0CFFQ28646329-6EC2A7E4-BAD3-40D2-BD57-6D56F41F0BCEQ33830825-61EA55AD-C042-4284-8E89-55FB2C768B77Q33856789-B85B6FDB-54FE-4DD1-8A4B-33F359AB86E2Q34210223-147345F1-24DB-4344-BA3A-2843A72DEA50Q34301760-D3ACBAAA-20A8-4452-AD1C-8A6BC74C1582Q34483921-18B5017E-DCCF-4DDB-8FBF-338CE4F02A28Q34551393-1AE49B81-01EA-4714-A2F3-7756A4857E64Q34587973-1B94DD03-99B0-4F2B-8C26-2FC6AE13EB02Q35982283-4AC7AD46-AF32-42A0-98AB-CCED39EA085AQ36125339-762D7AD2-9E24-4A5B-8A13-3895CBB618FEQ36798033-8FEE11FF-1125-4050-9A15-0E3D3CE4D46BQ37099581-78752AD8-EF9A-422B-AE34-A0532E438967Q37441223-954DF2BE-8699-46EF-AAD0-3DE48A13ECB8Q37711731-733B6446-6FF8-4629-ABD2-27A2C97ECF2CQ41875932-544A38C0-9C3C-422E-9DAF-D9EEA0B78890Q42157386-AB4A461D-A16F-4223-AD8C-F72941DD3DADQ42845410-44EFDC24-3135-4D69-97F1-B122B0A40092Q42856543-D8ECA11F-E849-4BA8-976B-003904F777B7Q44183079-19AFB683-EBBD-4709-8603-0F870ADF3058Q44257556-961253AA-245F-49B0-B6E5-53EC136CCF79Q47205530-F73820BD-0686-469B-914B-E5D82859C3C3Q53912632-9E13A8DC-DC87-410A-9412-FD466558ADB1
P2860
Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identification of residue 63 as beta-hydroxyaspartic acid
description
1983 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1983
@ast
im Juni 1983 veröffentlicher wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1983/06/07)
@sk
vědecký článek publikovaný v roce 1983
@cs
wetenschappelijk artikel (gepubliceerd op 1983/06/07)
@nl
наукова стаття, опублікована в червні 1983
@uk
مقالة علمية (نشرت في 7-6-1983)
@ar
name
Complete amino acid sequence o ...... 3 as beta-hydroxyaspartic acid
@ast
Complete amino acid sequence o ...... 3 as beta-hydroxyaspartic acid
@en
Complete amino acid sequence o ...... 3 as beta-hydroxyaspartic acid
@nl
type
label
Complete amino acid sequence o ...... 3 as beta-hydroxyaspartic acid
@ast
Complete amino acid sequence o ...... 3 as beta-hydroxyaspartic acid
@en
Complete amino acid sequence o ...... 3 as beta-hydroxyaspartic acid
@nl
prefLabel
Complete amino acid sequence o ...... 3 as beta-hydroxyaspartic acid
@ast
Complete amino acid sequence o ...... 3 as beta-hydroxyaspartic acid
@en
Complete amino acid sequence o ...... 3 as beta-hydroxyaspartic acid
@nl
P2093
P356
P1433
P1476
Complete amino acid sequence o ...... 3 as beta-hydroxyaspartic acid
@en
P2093
B. A. McMullen
B. Weinstein
K. Fujikawa
T. Sasagawa
W. N. Howald
P304
P356
10.1021/BI00281A016
P407
P577
1983-06-07T00:00:00Z